Scott L. Anchin
Net Worth
Last updated:
What is Scott L. Anchin net worth?
The estimated net worth of Mr. Scott L. Anchin is at least $1,411,498 as of 10 Mar 2021. He owns shares worth $895 as insider, has earned $110,603 from insider trading and has received compensation worth at least $1,300,000 in Applied DNA Sciences, Inc..
What is the salary of Scott L. Anchin?
Mr. Scott L. Anchin salary is $325,000 per year as Strategic Advisor & Independent Director in Applied DNA Sciences, Inc..
How old is Scott L. Anchin?
Mr. Scott L. Anchin is 51 years old, born in 1974.
What stocks does Scott L. Anchin currently own?
As insider, Mr. Scott L. Anchin owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Applied DNA Sciences, Inc. (APDN) | Strategic Advisor & Independent Director | 250 | $3.58 | $895 |
What does Applied DNA Sciences, Inc. do?
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Scott L. Anchin insider trading
Applied DNA Sciences, Inc.
Mr. Scott L. Anchin has made only one insider trade in 2021, according to the Form 4 filled with the SEC. He sold 13,049 units of APDN stock worth $110,603 on 10 Mar 2021.
As of 10 Mar 2021 he still owns at least 250 units of APDN stock.
Applied DNA Sciences key executives
Applied DNA Sciences, Inc. executives and other stock owners filed with the SEC:
- Dr. James A. Hayward Ph.D., Sc.D. (71) Chairman, Pres & Chief Executive Officer
- Mr. Scott L. Anchin (51) Strategic Advisor & Independent Director
- Ms. Beth M. Jantzen CPA, CPA (49) Chief Financial Officer
- Ms. Judith Murrah (67) Chief Operating Officer & Sec.